home / stock / zimv / zimv news


ZIMV News and Press, ZimVie Inc. From 05/03/23

Stock Information

Company Name: ZimVie Inc.
Stock Symbol: ZIMV
Market: NASDAQ
Website: zimvie.com

Menu

ZIMV ZIMV Quote ZIMV Short ZIMV News ZIMV Articles ZIMV Message Board
Get ZIMV Alerts

News, Short Squeeze, Breakout and More Instantly...

ZIMV - ZimVie Reports First Quarter 2023 Financial Results and Provides Update to Annual Guidance

Third Party Net Sales of $225.1 million Net Loss of ($30.0) million; Net Loss Margin of (13.3%); Adjusted Net Income [ 1] of $6.7 million Diluted EPS of ($1.14); Adjusted Diluted EPS [ 1] of $0.25 Adjusted EBITDA [ 1] ...

ZIMV - ZimVie Opens State-of-the-Art Dental Science Educational and Training Institute in Palm Beach Gardens, Florida

WESTMINSTER, Colo., April 27, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the opening of its new, state-of-the-art educational facility for dental practitioners in Palm Beach Gardens, Florida. ZimVie Institute...

ZIMV - ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug

WESTMINSTER, Colo., April 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launches of two additions to its biomaterials portfolio, the RegenerOss ® CC Allograft Particulate, a natural blend...

ZIMV - ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023

WESTMINSTER, Colo., April 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the first quarter 2023 after market close on Wednesday, May 3, 2023. Company management will host a corr...

ZIMV - ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®

WESTMINSTER, Colo., April 03, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the French Republic has published its approval for the reimbursement of the Mobi-C ® Cervical Disc in both the public and...

ZIMV - ZimVie's Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants

WESTMINSTER, Colo., March 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the publication of an article titled Comparison of the Effects of Tissue Processing on the Physicochemical Properties of Bone Allog...

ZIMV - ZimVie adds 15% most in four months on favorable coverage decisions

2023-03-15 15:04:08 ET Shares of the MedTech company ZimVie ( NASDAQ: ZIMV ) climbed ~15% , marking the highest intraday gain since November after announcing that two healthcare payers have issued positive medical policy decisions regarding vertebral body tethering (VBT). ...

ZIMV - Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK , March 3, 2023 /PRNewswire/...

ZIMV - Why ZimVie Stock Was Plummeting on Thursday

Specialty healthcare device maker ZimVie (NASDAQ: ZIMV) was hardly a special stock for many investors on Thursday. The company's shares were down a vertigo-inducing 46% in late-session trading, on the back of quarterly results that widely missed analyst estimates. ZimVie, which specia...

ZIMV - ZimVie crashes 37% to hit a post IPO-low after Q4 earnings

The shares of the MedTech company ZimVie ( NASDAQ: ZIMV ) lost ~37% in the morning hours Thursday to reach the lowest level since its 2022 IPO after reporting lower-than-expected Q4 2022 financials and setting its guidance below the consensus. ZimVie ( ZIMV ), which IPO’...

Previous 10 Next 10